ISHARES TR - U.S. MED DVC ETF (IHI)

Historical Holders from Q1 2014 to Q3 2025

Symbol
IHI
Type / Class
Equity / U.S. MED DVC ETF
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
28,049,288
Holdings value
$1,685,679,081
% of all portfolios
0.007%
Number of holders
513
Number of buys
146
Number of sells
-277
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ISHARES TR - U.S. MED DVC ETF (IHI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 28,049,288 $1,685,679,081 -$139,780,128 $60.08 513
2025 Q2 30,889,001 $1,934,008,589 -$71,129,888 $62.64 540
2025 Q1 32,041,775 $1,926,739,389 +$243,060,259 $60.19 549
2024 Q4 28,259,914 $1,650,015,884 -$370,655,958 $58.35 559
2024 Q3 34,262,358 $2,029,447,469 -$225,531,189 $59.22 550
2024 Q2 38,245,282 $2,143,068,382 -$86,251,564 $56.04 541
2024 Q1 39,518,066 $2,313,517,861 +$2,461,048 $58.59 576
2023 Q4 40,428,388 $2,182,412,405 -$55,966,831 $53.97 572
2023 Q3 41,264,588 $2,005,645,231 +$109,175,798 $48.5 539
2023 Q2 38,686,875 $2,181,537,226 -$172,775,979 $56.46 580
2023 Q1 41,867,910 $2,260,877,671 -$12,203,369 $53.98 550
2022 Q4 42,031,865 $2,211,056,470 -$45,315,080 $52.57 567
2022 Q3 43,464,582 $2,055,482,136 -$234,169,711 $47.18 542
2022 Q2 48,569,498 $2,448,683,360 +$15,986,913 $50.44 579
2022 Q1 47,889,171 $2,918,872,393 -$350,481,234 $60.96 622
2021 Q4 53,812,177 $3,539,114,281 +$81,661,366 $65.85 653
2021 Q3 49,806,746 $3,128,547,092 +$2,508,306,462 $62.78 564
2021 Q2 7,826,817 $2,826,778,825 -$1,137,455,368 $361.04 536
2021 Q1 11,686,783 $3,876,852,987 -$1,081,044,875 $330.36 561
2020 Q4 14,983,493 $4,910,407,530 +$110,672,621 $327.3 575
2020 Q3 14,494,165 $4,339,229,620 +$456,702,348 $299.62 482
2020 Q2 12,995,633 $3,443,480,026 +$1,394,578,161 $264.77 459
2020 Q1 7,705,659 $1,737,317,696 -$157,814,017 $225.35 358
2019 Q4 8,139,148 $2,151,439,880 +$22,823,971 $264.32 376
2019 Q3 8,076,810 $1,996,063,373 +$116,313,139 $247.23 312
2019 Q2 7,613,929 $1,832,788,402 +$8,518,611 $240.72 291
2019 Q1 7,578,758 $1,754,189,772 +$319,042,377 $231.53 266
2018 Q4 6,256,494 $1,249,925,581 -$250,468,417 $199.81 229
2018 Q3 7,345,896 $1,670,720,723 +$295,357,397 $227.48 225
2018 Q2 6,038,961 $1,211,402,838 +$288,823,941 $200.65 187
2018 Q1 4,605,252 $851,668,108 +$75,523,046 $185.01 170
2017 Q4 4,201,986 $729,318,026 -$22,018,662 $173.51 170
2017 Q3 4,198,388 $701,394,684 -$102,158,472 $167.03 152
2017 Q2 5,014,171 $833,466,094 +$276,958,082 $166.61 158
2017 Q1 3,303,802 $500,691,640 +$44,034,893 $151.42 137
2016 Q4 3,708,859 $494,781,026 -$404,210,376 $133.15 107
2016 Q3 6,663,640 $968,079,692 +$112,818,089 $145.39 120
2016 Q2 5,945,139 $805,981,791 +$209,116,207 $135.55 108
2016 Q1 4,353,811 $533,325,007 +$105,363,620 $122.48 86
2015 Q4 3,500,375 $428,477,854 -$45,909,878 $122.47 83
2015 Q3 3,866,524 $431,020,000 -$612,061 $111.29 80
2015 Q2 3,873,425 $463,914,273 -$43,550,470 $119.73 73
2015 Q1 4,279,973 $514,766,818 -$18,272,616 $120.29 75
2014 Q4 4,449,955 $503,398,772 +$91,171,916 $113.11 79
2014 Q3 2,244,139 $223,076,246 +$1,398,615 $99.4 65
2014 Q2 2,226,745 $227,170,440 +$3,341,561 $102.02 69
2014 Q1 2,193,592 $216,544,433 +$33,508,508 $98.81 60